National trends in keloid treatment revealed the greatest utilization of treatment among women and those in the finance and service industries.

The overall second primary malignancy point estimate was 5.8% for patients receiving chimeric antigen receptor T-cell therapy.

The decision to use b/tsDMARD monotherapy vs combination therapy with MTX when treating PsA is primarily based on patient satisfaction and drug tolerability.

Results of a cross-sectional, observational study of UK biobank data suggest severe vitamin D deficiency may be associated with chronic widespread pain.

No new safety concerns and consistent safety profiles were observed for long-term risankizumab use in patients with psoriasis and PsA.

Implementation of opt-out emergency department syphilis screening leads to a dramatic increase in screening and diagnosis, especially among pregnant individuals.

HPV vaccination was highly effective against anal HPV in a cohort of HIV-negative MSM, particularly when vaccination occurred at younger ages.